Cinfa participates in the 35th Annual Conference of the
Saudi Heart Association
(Riyadh, Saudi Arabia) - The European pharmaceutical company
Cinfa has again
participated at the 35th
Annual Conference of the
Saudi Heart Association held
in Saudi Arabia.
Cinfa is
committed to contributing
its knowledge and expertise
in cardiology, one of the
most challenging areas
facing the healthcare and
pharmacological sectors. The
group’s main objective for
participating in this
reference conference, as
highlighted by Mikel
Zumalabe Martinez,
International Marketing
Manager at Cinfa Group, was
“collaborating with the
Saudi Heart Association in
raising awareness about the
risks of cardiovascular
disease (CVD), emphasizing
our commitment to the CVD
patients and our constant
responsibility toward
providing authentic and
accessible medicines that
effectively control the CVD
diseases and therefore
preventing the CVD adverse
events”.
This goal is
aligned with the Saudi Heart
Association’s mission of
leading and conducting
applied research on
cardiovascular disease,
representing cardiovascular
medicine both nationally and
internationally.
As Dr.
Alicia López de Ocáriz,
Corporate Medical Director
of the Cinfa Group has
highlighted, ‘’Cinfa’s main
challenge is to continue
offering patients medicines
that help in the treatment
and prevention of
cardiovascular diseases,
improving their quality of
life and reducing the number
of hospitalizations that
represent the greatest
expense associated with this
disease".
Cardiovascular
diseases continue to be the
leading cause of death and
pose a major challenge for
healthcare systems
worldwide. However, Saudi
Arabia's healthcare sector
is evolving, driven by rapid
progress in cardiac
technology, research and
development, medications,
interventions, and
healthcare infrastructure,
all in alignment with global
and regional trends. These
significant advancements
allow the Saudi healthcare
system and its experienced
healthcare professionals to
address this challenge. On
this point, Cinfa tries to
contribute by providing
quality and effective
solutions in the treatment
of cardiovascular diseases,
with a focus on patient care
to minimize the patients
suffering.
